Skip to main content
. 2019 Nov 29;10(1):23–34. doi: 10.1016/j.jpha.2019.11.008

Fig. 3.

Fig. 3

(A) BPC for RP-MS analysis of the IdeS digested infliximab drug product. (B) Zoom of charge state +30 for scFc peaks containing (top) and missing (down) C-term lysine.